Lamotrigina Generis

Lamotrigine, the active ingredient in Lamotrigina Generis, is a sodium channel blocker presented as an oral tablet for oral use. It is prescribed for the management of epilepsy and bipolar disorder, helping to control seizures and stabilize mood in adult patients. The medication works by modulating neuronal excitability and reducing excessive glutamate release.

GNH USA supplies Lamotrigina Generis as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide.

Lamotrigine is used in neurological and psychiatric conditions that involve abnormal neuronal firing or mood instability. - Epilepsy: reduces the frequency and severity of partial and generalized seizures. - Bipolar disorder: stabilizes mood and decreases the risk of manic or depressive episodes. - Adjunctive therapy for focal seizures: used alongside other antiepileptic drugs to improve seizure control.

Lamotrigine may cause a range of adverse reactions, most of which are mild and transient.

Common Side Effects: - Headache: mild to moderate pain often reported during early treatment. - Dizziness: sensation of light‑headedness, especially when standing quickly. - Nausea: occasional stomach upset or queasiness. - Rash: mild skin irritation or erythema. - Insomnia: difficulty falling or staying asleep. - Fatigue: feeling unusually tired or weak.

Serious or Rare Side Effects: - Stevens‑Johnson syndrome: severe skin reaction with blistering and mucosal involvement. - Toxic epidermal necrolysis: life‑threatening skin detachment. - Aseptic meningitis: inflammation of the meninges without infection. - Blood dyscrasias: rare cases of agranulocytosis or pancytopenia. - Hepatic failure: severe liver injury reported in isolated cases. - Suicidal ideation: emergence or worsening of suicidal thoughts.

When prescribing Lamotrigina Generis, clinicians should consider several safety measures. - Initiate therapy at low dose: start with a minimal dose and titrate slowly to reduce rash risk. - Monitor skin reactions: discontinue immediately if a rash develops and assess for severe cutaneous reactions. - Assess hepatic function: evaluate liver enzymes before and during treatment, especially in patients with pre‑existing liver disease. - Review concomitant medications: avoid drugs that significantly alter lamotrigine metabolism. - Pregnancy and lactation: discuss unknown risks with patients of child‑bearing potential. - Store at ambient temperature: keep below 25 °C, in the original container, protected from moisture and direct sunlight.

Lamotrigine interacts with several medicines that can alter its plasma concentration.

Major Interactions (Avoid): - Valproic acid: markedly increases lamotrigine levels, raising the risk of severe rash. - Carbamazepine: reduces lamotrigine exposure, potentially compromising efficacy. - Phenobarbital: accelerates lamotrigine clearance, requiring dose adjustments.

Moderate Interactions (Monitor Closely): - Oral contraceptives: may lower lamotrigine concentrations, necessitating monitoring of seizure control. - Serotonergic agents: combined use may increase the risk of serotonin syndrome. - Other antiepileptic drugs (e.g., phenytoin, primidone): may modestly affect lamotrigine metabolism.